Table 3.
Comparisons of Characteristics between different portal hypertension grades after Propensity Score Matching.
| Characteristics | Total (N= 186) | PH grade 0 (N= 62) | PH grade 1 (N= 62) | PH grade 2 (N= 62) | P value |
|---|---|---|---|---|---|
| Age, years | 52 (45 - 58) | 51 (45 - 56) | 54 (45 - 57.8) | 53.5 (46 - 58.8) | 0.178 |
| Gender | 0.882 | ||||
| Female | 22 (11.83) | 6 (9.68) | 8 (12.9) | 8 (12.9) | |
| Male | 164 (88.17) | 56 (90.32) | 54 (87.1) | 54 (87.1) | |
| ASA classification | 0.711 | ||||
| Grade 1 | 47 (25.27) | 14 (22.58) | 15 (24.19) | 18 (29.03) | |
| Grade 2 | 121 (65.05) | 44 (70.97) | 40 (64.52) | 37 (59.68) | |
| Grade 3 | 18 (9.68) | 4 (6.45) | 7 (11.29) | 7 (11.29) | |
| Etiology | |||||
| HBV | 0.732 | ||||
| NO | 17 (9.14) | 7 (11.29) | 4 (6.45) | 6 (9.68) | |
| YES | 169 (90.86) | 55 (88.71) | 58 (93.55) | 56 (90.32) | |
| HCV | 0.999 | ||||
| NO | 182 (97.85) | 60 (96.77) | 61 (98.39) | 61 (98.39) | |
| YES | 4 (2.15) | 2 (3.23) | 1 (1.61) | 1 (1.61) | |
| Alcoholic | 0.999 | ||||
| NO | 183 (98.39) | 61 (98.39) | 61 (98.39) | 61 (98.39) | |
| YES | 3 (1.61) | 1 (1.61) | 1 (1.61) | 1 (1.61) | |
| Others | 0.776 | ||||
| NO | 176 (94.62) | 58 (93.55) | 60 (96.77) | 58 (93.55) | |
| YES | 10 (5.38) | 4 (6.45) | 2 (3.23) | 4 (6.45) | |
| HBV DNA | 0.900 | ||||
| <500 Copys | 95 (51.08) | 32 (51.61) | 30 (48.39) | 33 (53.23) | |
| >500 Copys | 91 (48.92) | 30 (48.39) | 32 (51.61) | 29 (46.77) | |
| Cirrhosis status | 0.999 | ||||
| NO | 4 (2.15) | 1 (1.61) | 1 (1.61) | 2 (3.23) | |
| YES | 182 (97.85) | 61 (98.39) | 61 (98.39) | 60 (96.77) | |
| Surgical approach | 0.688 | ||||
| Laparoscopy | 83 (44.62) | 30 (48.39) | 25 (40.32) | 28 (45.16) | |
| Open | 103 (55.38) | 32 (51.61) | 37 (59.68) | 34 (54.84) | |
| Extent of resection | 0.999 | ||||
| Minor | 175 (94.09) | 58 (93.55) | 59 (95.16) | 58 (93.55) | |
| Major | 11 (5.91) | 4 (6.45) | 3 (4.84) | 4 (6.45) | |
| Hepatic inflow occlusion | 0.891 | ||||
| NO | 65 (34.95) | 20 (32.26) | 23 (37.1) | 22 (35.48) | |
| YES | 121 (65.05) | 42 (67.74) | 39 (62.9) | 40 (64.52) | |
| Intraoperative blood loss | 0.999 | ||||
| <400 ml | 118 (63.44) | 39 (62.9) | 39 (62.9) | 40 (64.52) | |
| ≥400 ml | 68 (36.56) | 23 (37.1) | 23 (37.1) | 22 (35.48) | |
| Intraoperative transfution | 0.743 | ||||
| NO | 138 (74.19) | 48 (77.42) | 44 (70.97) | 46 (74.19) | |
| YES | 48 (25.81) | 14 (22.58) | 18 (29.03) | 16 (25.81) | |
| Tumor number | 0.962 | ||||
| Single | 162 (87.1) | 53 (85.48) | 55 (88.71) | 54 (87.1) | |
| Multipe(≥2) | 24 (12.9) | 9 (14.52) | 7 (11.29) | 8 (12.9) | |
| Tumor size, cm | 3 (2 - 4) | 3.5 (2.7 - 4.9) | 3 (2 - 3.6) | 3 (2 - 4) | 0.515 |
| ALT, U/L | 34 (23 - 45) | 34 (25 - 51.8) | 36 (23 - 50.5) | 33 (23 - 43) | 0.425 |
| AST, U/L | 32 (24 - 47) | 31.5 (23 - 46.8) | 35.5 (25 - 52.8) | 32.5 (24.2 - 44) | 0.828 |
| Albumin, g/L | 38.8 (35 - 41) | 39.2 (37.1 - 42.1) | 37.8 (34.1 - 40.9) | 38 (35.5 - 40.2) | 0.379 |
| Total bilirubin, μmol/L | 16.8 (11.9 - 21.3) | 16.4 (11.9 - 21) | 17.9 (12.1 - 25.1) | 16.6 (11.8 - 19.8) | 0.566 |
| Creatinine, μmol/L | 77 (65 - 84) | 77.5 (65 - 84) | 76.5 (62.5 - 83) | 77.5 (69.2 - 86.5) | 0.614 |
| PT, s | 13.4 (12.3 - 14.8) | 13.6 (12 - 14.8) | 13.1 (12.1 - 14.2) | 13.5 (12.5 - 14.8) | 0.854 |
| RBC, 1012/L | 4.4 (4 - 4.8) | 4.5 (3.9 - 4.9) | 4.3 (4.1 - 4.7) | 4.4 (3.9 - 4.8) | 0.479 |
| AFP, ng/ml | 60.7 (12.1 - 619.7) | 159.1 (16 - 773.2) | 37.8 (7.8 - 527.4) | 37.1 (12.1 - 540.1) | 0.449 |
| Platelet, 109/L | 90.5 (65.6 - 149) | 160.5 (114.5 - 176) | 92 (71.8 - 149) | 63.5 (50.1 - 81) | 0.006 |
| Child-Pugh class | 0.652 | ||||
| Grade A | 165 (88.71) | 54 (87.1) | 57 (91.94) | 54 (87.1) | |
| Grade B | 21 (11.29) | 8 (12.9) | 5 (8.06) | 8 (12.9) | |
| Meld score | 6.2 (4.5 - 8.2) | 6.2 (4.7 - 8.2) | 6.2 (4.8 - 8.3) | 6.4 (4.3 - 8.1) | 0.587 |
| PHLF | 0.041 | ||||
| NO | 131 (70.43) | 48 (77.42) | 47 (75.81) | 36 (58.06) | |
| YES | 55 (29.57) | 14 (22.58) | 15 (24.19) | 26 (41.94) | |
PH, portal hypertension; ASA, American Society of Anesthesiologists; HBV, Hepatitis B virus; HCV, Hepatitis C virus; ALT, alanine transaminase; AST, aspartate transaminase; PT, prothrombin time; RBC, red blood cell; AFP, a-fetoprotein level; MELD, Model For End-Stage Liver Disease; PHLF, post hepatectomy liver failure. Values with P < 0.05 in the tables are in bold.